Global Cell and Gene Therapy Thawing Equipment Market is Expected to grow at 14.2% in the Forecast Period of 2021 to 2028

Cell and Gene Therapy Thawing Equipment Market is growing with factors such as the surge in incidence of genetic diseases such as cystic fibrosis and sickle cell anemia and the rise in investment in research and development for development of cell and gene therapies. The other factors which are anticipated to propel the growth of the global cell and gene therapy thawing equipment market is the strategic initiative by market players and rise in expenditure in healthcare sector. It bolsters the cell and gene therapy thawing equipment market growth.

However, the strict regulatory framework and the disruption in supply chain management due to the pandemic and longtime approval for immunotherapies may obstruct the growth of the market in the given forecast period.

Global Cell and Gene Therapy Thawing Equipment Market Scenario

According to Data Bridge Market Research, the market for the cell and gene therapy thawing equipment is dominating in North America. Merck KGaA and Eppendorf AG are dominating players in the market which accounts an estimated market share of approximately 12.88% and 11.82%. The company has gained outstanding sale through rise of thawing instruments and clinical trials for cell and gene therapies.

  • In October 2020, Merck KGaA, had launched the VirusExpress Lentiviral Production Platform. The rise of the Virus Express Lentiviral Production Platform would result in overcoming the challenges in lentiviral production, and reducing the process development by 40% and would provide lucrative opportunities for curative treatments.

Cell and Gene Therapy Thawing Equipment Market Trends Impacting the Market

Now the question is which other regions is Merck KGaA, Eppendorf AG and SGS SA are targeting? Data Bridge Market Research has estimated a large growth in North America cell and gene therapy thawing equipment market and the market leaders targeting the U.S. Canada, and Mexico to be their next revenue pockets for 2021.

The global cell and gene therapy thawing equipment market is becoming more competitive with companies such as, Merck KGaA, Eppendorf AG, and SGS SA. These are the market leader of this market. Data Bridge Market Research new reports highlight the major growth factors and opportunities in the global cell and gene therapy thawing equipment market.

For more analysis on the global cell and gene therapy thawing equipment market, request for a briefing with our analysts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-cell-and-gene-therapy-thawing-equipment-market

Global Cell and Gene Therapy Thawing Equipment Market Development

  • In May 2018, Eurofins Scientific had increased the biopharmaceutical products testing footprint with an outsourcing agreement with Astellas in Japan. The product expansion took place due to the company forming an agreement with Astellas to outsource the internal testing laboratories named as Astellas Analytical Science Laboratories, Inc. (“ASL”). ASL has offered the test services with good manufacturing practices in Japan. The outsourcing had expanded the growing footprint in Asia Pacific, and provides a good platform to further expand in the biopharmaceutical products testing market in Asia.

Scope of the Global Cell and Gene Therapy Thawing Equipment Market

Global cell and gene therapy thawing equipment market is segmented on the basis of countries, which are U.S., Canada and Mexico, Germany, U.K., France, Spain, Italy, Russia, Lithuania, Switzerland, Turkey, Belgium, and Rest of Europe, Japan, China, India, Taiwan, South Korea, Australia, Singapore, New Zealand, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, UAE, Saudi Arabia, Israel, Egypt and Rest of Middle East and Africa.

  • All country-based analysis of global cell and gene therapy thawing equipment market is further analyzed based on further segmentation. On the basis of modality, the global cell and gene therapy thawing equipment market is segmented into benchtop and portable. On the basis of product, the global cell and gene therapy thawing equipment market is segmented into finished goods, electronics and raw materials. On the basis of sample, the global cell and gene therapy thawing equipment market is segmented into cell therapies and gene therapies. On the basis of type, the global cell and gene therapy thawing equipment market is segmented into manual thawing system and automatic thawing system. On the basis of Application, the global cell and gene therapy thawing equipment market is segmented into upstream processing and downstream processing. On the basis of end user, the global cell and gene therapy thawing equipment market is segmented into hospitals and diagnostic laboratories, blood banks and transfusion centres, research laboratories and academic institutes, biotechnology and pharmaceutical industry, cord blood and stem cell banks, gene banks and others. On the basis of distribution channel, the global cell and gene therapy thawing equipment market is segmented into direct tender, third party distributors and others.

To know more about the study https://www.databridgemarketresearch.com/reports/global-cell-and-gene-therapy-thawing-equipment-market

Key Pointers Covered in Global Cell and Gene Therapy Thawing Equipment Market Industry Trends and Forecast to 2028

  • Market Size
  • Top to Bottom Market Analysis
  • Recent Developments for Market Competitors
  • Recent Market Value for Different Countries

Key Market Competitors Covered in the Report

  • Merck KGaA
  • Eppendorf AG
  • Sartorius AG
  • Cytiva (A subsidiary of Danaher Corporation)
  •  Pluristem Therapeutics Inc.
  • Genesis BPS
  • Cook
  •  SARSTEDT AG & Co. KG
  • Barkey
  • Boekel Scientific
  • LABCOLD
  • BIOLINE INDIA
  • Helmer Scientific Inc.

Above are the key players covered in the report, to know about more and exhaustive list of the cell and gene therapy thawing equipment market companies’, contact us https://www.databridgemarketresearch.com/toc/?dbmr=global-cell-and-gene-therapy-thawing-equipment-market

Research Methodology: Global Cell and Gene Therapy Thawing Equipment Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Primary Respondents

  • Demand Side: Chief Level Officers, Product and Marketing Manager, Manufacturers, Distributors, Buyers.
  • Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence, and Regulatory Affairs Managers among others.

Related Reports

Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/report-category/healthcare/